Advantages of a Technique Using Two 50 Degree Arcs in Simultaneous Integrated Boost Radiotherapy for Left-sidebreast Cancer

Overview

Journal Sci Rep

Specialty Science

Date 2017 Nov 9

PMID 29116237

Citations 5

Authors

Dan Xi

Yun Ding

Rui Hu

Wendong Gu

Jinming Mu

Qilin Li

Affiliations

Soon will be listed here.

Abstract

This study evaluated radiotherapy techniques with 15 cases for simultaneous integrated boost to treat whole left breast and tumor bed following breast conserving surgery. Treatment plans were generated using three techniques: volumetric modulated arc therapy (VMAT) with a partial arc of 190° (1ARC), VMAT with two tangential mini-arcs of 50° each (2TARC) and intensity modulated radiation therapy with four fixed angle fields (4IMRT). Dosimetric parameters for the whole breast (Target), the boost tumor bed (Boost), and surrounding normal organs were compared. Chair Index (CHI) was introduced to evaluate the dose homogeneity in Target given the two levels of prescription dose. The dose coverage in Target was better in 1ARC and 2TARC than that in 4IMRT. The mean CHI in 1ARC (2.47) and 2TARC (2.62) were higher than that in 4IMRT (1.71, p < 0.05), and this indicated the dose homogeneity of Target was better in 1ARC and 2TARC than that in 4IMRT. The mean doses to right lung, and contralateral breast in 4IMRT were lower than those in 2TARC but the differences between them were small. 2TARC was better than 4IMRT with respect to the dose to ipsilateral lung and heart. Overall, 2TARC was optimal among three techniques.

Citing Articles

Dose and organ displacement comparisons with breast conservative radiotherapy using abdominal and thoracic deep-inspiration breath-holds: A comparative dosimetric study.

Matsumoto Y, Kunieda E, Futakami N, Akiba T, Nagao R, Fukuzawa T J Appl Clin Med Phys. 2023; 24(4):e13888.

PMID: 36617188 PMC: 10113706. DOI: 10.1002/acm2.13888.

Knowledge-based DVH estimation and optimization for breast VMAT plans with and without avoidance sectors.

Fogliata A, Parabicoli S, Paganini L, Reggiori G, Lobefalo F, Cozzi L Radiat Oncol. 2022; 17(1):200.

PMID: 36474297 PMC: 9724419. DOI: 10.1186/s13014-022-02172-6.

Examination of the dose distribution of volumetric modulated arc radiotherapy using a high-definition multi-leaf collimator for breast cancer patients with irradiated regional lymph nodes.

Matsumoto Y, Kunieda E, Futakami N, Akiba T, Nagao R, Fukuzawa T Rep Pract Oncol Radiother. 2022; 27(4):634-643.

PMID: 36196412 PMC: 9521697. DOI: 10.5603/RPOR.a2022.0081.

New fractionations in breast cancer: a dosimetric study of 3D-CRT versus VMAT.

Piras A, Menna S, DAviero A, Marazzi F, Mazzini A, Cusumano D J Med Radiat Sci. 2021; 69(2):227-235.

PMID: 34551211 PMC: 9163458. DOI: 10.1002/jmrs.530.

Evaluation of abches and volumetric modulated arc therapy under deep inspiration breath-hold technique for patients with left-sided breast cancer: A retrospective observational study.

Yeh T, Chi M, Chi K, Hsu C Medicine (Baltimore). 2019; 98(39):e17340.

PMID: 31574873 PMC: 6775396. DOI: 10.1097/MD.0000000000017340.

References

Fogliata A, Seppala J, Reggiori G, Lobefalo F, Palumbo V, De Rose F . Dosimetric trade-offs in breast treatment with VMAT technique. Br J Radiol. 2016; 90(1070):20160701. PMC: 5685098. DOI: 10.1259/bjr.20160701. View

Zhao H, He M, Cheng G, Han D, Wu N, Shi D . A comparative dosimetric study of left sided breast cancer after breast-conserving surgery treated with VMAT and IMRT. Radiat Oncol. 2015; 10:231. PMC: 4650319. DOI: 10.1186/s13014-015-0531-4. View

Liu H, Chen X, He Z, Li J . Evaluation of 3D-CRT, IMRT and VMAT radiotherapy plans for left breast cancer based on clinical dosimetric study. Comput Med Imaging Graph. 2016; 54:1-5. DOI: 10.1016/j.compmedimag.2016.10.001. View

Fippel M . Fast Monte Carlo dose calculation for photon beams based on the VMC electron algorithm. Med Phys. 1999; 26(8):1466-75. DOI: 10.1118/1.598676. View

Badakhshi H, Kaul D, Nadobny J, Wille B, Sehouli J, Budach V . Image-guided volumetric modulated arc therapy for breast cancer: a feasibility study and plan comparison with three-dimensional conformal and intensity-modulated radiotherapy. Br J Radiol. 2013; 86(1032):20130515. PMC: 3856548. DOI: 10.1259/bjr.20130515. View

Aly M, Glatting G, Jahnke L, Wenz F, Abo-Madyan Y . Comparison of breast simultaneous integrated boost (SIB) radiotherapy techniques. Radiat Oncol. 2015; 10:139. PMC: 4495684. DOI: 10.1186/s13014-015-0452-2. View

Mondal D, Julka P, Sharma D, Jana M, Laviraj M, Deo S . Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: A phase I/II dosimetric and clinical feasibility study from a tertiary cancer care centre.... J Egypt Natl Canc Inst. 2017; 29(1):39-45. DOI: 10.1016/j.jnci.2017.01.005. View

De Rose F, Fogliata A, Franceschini D, Navarria P, Villa E, Iftode C . Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results. Radiat Oncol. 2016; 11(1):120. PMC: 5027088. DOI: 10.1186/s13014-016-0701-z. View

Wu S, Lai Y, He Z, Zhou Y, Chen S, Dai M . Dosimetric comparison of the simultaneous integrated boost in whole-breast irradiation after breast-conserving surgery: IMRT, IMRT plus an electron boost and VMAT. PLoS One. 2015; 10(3):e0120811. PMC: 4363530. DOI: 10.1371/journal.pone.0120811. View

10.

Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M . Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011; 378(9804):1707-16. PMC: 3254252. DOI: 10.1016/S0140-6736(11)61629-2. View

11.

Fiorentino A, Mazzola R, Ricchetti F, Giaj Levra N, Fersino S, Naccarato S . Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity. Cancer Radiother. 2015; 19(5):289-94. DOI: 10.1016/j.canrad.2015.02.013. View

12.

Haciislamoglu E, Colak F, Canyilmaz E, Dirican B, Gurdalli S, Yilmaz A . Dosimetric comparison of left-sided whole-breast irradiation with 3DCRT, forward-planned IMRT, inverse-planned IMRT, helical tomotherapy, and volumetric arc therapy. Phys Med. 2015; 31(4):360-7. DOI: 10.1016/j.ejmp.2015.02.005. View

13.

Scorsetti M, Alongi F, Fogliata A, Pentimalli S, Navarria P, Lobefalo F . Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments. Radiat Oncol. 2012; 7:145. PMC: 3488023. DOI: 10.1186/1748-717X-7-145. View

14.

Nitsche M, Pahl R, Huber K, Eilf K, Dunst J . Cardiac Toxicity after Radiotherapy for Breast Cancer: Myths and Facts. Breast Care (Basel). 2015; 10(2):131-5. PMC: 4464015. DOI: 10.1159/000376560. View

15.

Thilmann C, Zabel A, Nill S, Rhein B, Hoess A, Haering P . Intensity-modulated radiotherapy of the female breast. Med Dosim. 2002; 27(2):79-90. DOI: 10.1016/s0958-3947(02)00089-4. View

16.

Hamilton D, Bale R, Jones C, Fitzgerald E, Khor R, Knight K . Impact of tumour bed boost integration on acute and late toxicity in patients with breast cancer: A systematic review. Breast. 2016; 27:126-35. DOI: 10.1016/j.breast.2016.03.002. View

17.

Nitsche M, Dunst J, Carl U, Hermann R . Emerging Role of Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Modern Radiotherapy of Breast Cancer. Breast Care (Basel). 2015; 10(5):320-4. PMC: 4677707. DOI: 10.1159/000436951. View

18.

Yu J, Hu T, Chen Y . Small-arc volumetric-modulated arc therapy: A new approach that is superior to fixed-field IMRT in optimizing dosimetric and treatment-relevant parameters for patients undergoing whole-breast irradiation following breast-conserving surgery. Medicine (Baltimore). 2016; 95(34):e4609. PMC: 5400323. DOI: 10.1097/MD.0000000000004609. View